✦ LIBER ✦

Enhancement of tumor cell susceptibility to tumor-infiltrating lymphocytes by cisplatin

✍ Scribed by Kohei Noguchi; Hiroshi Tanimura; Hiroki Yamaue; Makoto Iwahashi; Takuya Tsunoda; Masaji Tani; Mikiko Tamai; Tsukasa Hotta; Shizuma Mizobata; Kazuo Arii

Publisher: Springer-Verlag
Year: 1997
Tongue: English
Weight: 686 KB
Volume: 123
Category: Article
ISSN: 1432-1335
DOI: 10.1007/bf01438311

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lysis by interleukin 2-stimulated tumor-

Lysis by interleukin 2-stimulated tumor-infiltrating lymphocytes of autologous and allogeneic tumor target cells

✍ Marina Radrizzani; Carlo Gambacorti-Passerini; Giorgio Parmiani; Giuseppe Fossat 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 English ⚖ 777 KB

Peripheral blood lymphocytes (PBL) and tumor-infiltrating lymphocytes (TIL) were isolated from six cancer patients and cultured in the presence of 100 units/ml of recombinant interleukin 2 (IL2). Both IL2-stimulated PBL (IL2-PBL) and IL2-stimulated TIL (IL2-TIL) lysed fresh and short-term cultured a

T-cell markers in tumor-infiltrating lym

T-cell markers in tumor-infiltrating lymphocytes of head and neck cancer

✍ Dr. Carl H. Snyderman; D. S. Heo; K. Chen; Theresa L. Whiteside; Jonas T. Johnso 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

Fresh suspensions of tumor-infiltrating lymphocytes (TIL) from 16 patients with squamous cell carcinoma of the head and neck (SCCHN) were examined for T-cell markers including CD4 (helper-inducer), CD8 (cytotoxic-suppressor), natural killer (NK) cell, and activation surface markers using monoclonal

Augmentation of cytotoxicity of tumor-in

Augmentation of cytotoxicity of tumor-infiltrating lymphocytes by biological response modifiers

✍ Kiyotoshi Gotoh; Akira Gouchi; Yosikazu Akura; Noriaki Tanaka; Kunzo Orita 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 519 KB

GD3-reactive antibodies can inhibit the

GD3-reactive antibodies can inhibit the lysis of autologous tumor cells by tumor-infiltrating lymphocytes

✍ Edward B. Reilly; Giovanna Antognetti 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

Effects of HC antibody in autologous tum

Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes

✍ Paul F. Mansfield; Marie A. Salmeron; Michael G. Rosenblum; Kyogo Itoh 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 689 KB

## Abstract Heteroconjugate (HC) antibody has a potential use in cancer biotherapy because of its ability to mimic antigenic specificity and induce cytotoxicity in the activated lymphocytes against various tumor cells. This study investigated the effects of HC antibody (anti‐CD3 MAb x anti‐p97 mela

MHC-dependent cytolysis of autologous tu

MHC-dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas

✍ Franck Housseau; Dominique Zeliszewski; Maguy Roy; Valerie Paradis; Sophie Richo 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 143 KB

Tumor-infiltrating lymphocytes (TIL) were grown from 23 urothelial carcinomas. Phenotyping analysis showed that the TIL cultures were mainly CD3 1 . Although CD4 1 and CD8 1 T-cell sub-sets were grown in culture, CD4 1 T-cell sub-sets predominated over CD8 1 T cells. Immunohistochemical studies perf